Product image of Kalinor-Retard P (Potassium Chloride) supplied by GNH India

Kalinor-Retard P

Active Ingredient:
Potassium Chloride
Origin:
EU

Kalinor-Retard P (Potassium Chloride)

Potassium Chloride, the active ingredient in Kalinor-Retard P, is an electrolyte supplement presented as an oral dosage form for oral use. It replaces potassium ions and corrects hypokalemia in patients with potassium loss or deficiency.

GNH India supplies Kalinor-Retard P as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Desma Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Kalinor-Retard P, a potassium supplement, is used to correct potassium deficits in conditions that cause hypokalemia.

  • Hypokalemia: restores normal serum potassium concentrations.
  • Potassium deficiency: prevents clinical complications associated with low potassium levels.
  • Cardiac arrhythmia risk: reduces the likelihood of rhythm disturbances caused by inadequate potassium.

How It Works

  • Potassium Chloride dissociates in the gastrointestinal tract, releasing potassium ions that are absorbed primarily in the small intestine. The absorbed potassium enters the extracellular fluid, increasing serum potassium levels and re‑establishing the electrochemical gradient essential for nerve impulse transmission, muscle contraction, and cardiac electrophysiology.

Side Effects

Kalinor-Retard P may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects

  • Nausea: mild to moderate upset stomach.
  • Abdominal discomfort: cramping or pain in the abdomen.
  • Diarrhea: loose stools occurring after ingestion.
  • Vomiting: occasional expulsion of stomach contents.
  • Taste disturbance: metallic or salty taste perception.
  • Flatulence: increased intestinal gas.

Serious or Rare Side Effects

  • Hyperkalemia: dangerously high serum potassium levels.
  • Cardiac arrhythmia: irregular heart rhythm potentially leading to serious events.
  • Muscle weakness: severe weakness affecting mobility.
  • Severe allergic reaction: rash, itching, swelling, or difficulty breathing.
  • Metabolic acidosis: imbalance in blood pH in rare cases.
  • Respiratory distress: shortness of breath in extreme hyperkalemia.

Precautions & Warnings

When prescribing Kalinor-Retard P, clinicians should consider several safety measures.

  • Renal impairment: assess kidney function and adjust dose as needed.
  • Cardiac disease: monitor ECG and serum potassium closely.
  • Concomitant potassium‑sparing diuretics: avoid additive hyperkalemia risk.
  • ACE inhibitors or ARBs: increase monitoring of potassium levels.
  • Hyperkalemia: discontinue immediately if serum potassium exceeds safe limits.
  • Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Avoid Interactions

Potassium chloride can interact with several medications, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid)

  • ACE inhibitors: may cause excessive potassium accumulation.
  • Angiotensin receptor blockers: increase risk of hyperkalemia.
  • Potassium‑sparing diuretics: additive potassium load.
  • NSAIDs: reduce renal potassium excretion.
  • Trimethoprim: potentiates hyperkalemia.

Moderate Interactions (Monitor Closely)

  • Digoxin: heightened risk of toxicity with high potassium.
  • Beta‑blockers: may mask symptoms of hyperkalemia.
  • Certain antibiotics (e.g., penicillins): can affect renal handling of potassium.
  • Insulin: may shift potassium intracellularly, altering serum levels.
  • Glucocorticoids: influence potassium balance.

Frequently Asked Questions

Kalinor-Retard P is an oral potassium supplement used to treat hypokalemia and potassium deficiency. It helps restore normal serum potassium levels in patients who have lost potassium due to illness, medication, or dietary insufficiency, thereby supporting proper muscle, nerve, and cardiac function.

Potassium chloride dissociates after oral ingestion, releasing potassium ions that are absorbed in the small intestine. The absorbed potassium enters the extracellular fluid, raising serum potassium concentrations and re‑balancing the electrochemical gradients essential for nerve impulse transmission, muscle contraction, and heart rhythm regulation.

The dose of Kalinor-Retard P is individualized by the prescribing clinician based on the patient’s serum potassium level, underlying condition, renal function, and concurrent medications. The prescriber determines the appropriate strength and frequency to safely correct the potassium deficit.

Safety data for Kalinor-Retard P in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare professional after careful assessment.

To order Kalinor-Retard P, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and necessary import documentation.

Kalinor-Retard P provides potassium chloride, the most common and bioavailable form of oral potassium replacement. Compared with potassium gluconate or potassium citrate, chloride offers rapid absorption and is widely used for acute correction of hypokalemia, though individual tolerance and electrolyte balance must be considered.

Store Kalinor-Retard P at ambient temperature, preferably below 25 °C, in its original packaging. Protect the product from moisture, direct sunlight, and extreme temperatures to maintain potency and prevent degradation.

Kalinor-Retard P is taken orally, usually with a glass of water. The tablet should be swallowed whole and not chewed or crushed unless specifically directed by a healthcare professional. Administration timing may be adjusted based on the prescriber’s instructions and the patient’s clinical status.

The most serious risk is hyperkalemia, which can cause cardiac arrhythmias, muscle weakness, or respiratory failure. Patients with renal impairment, heart disease, or those taking other potassium‑raising agents should be closely monitored for elevated serum potassium levels.

Kalinor-Retard P should be avoided in patients with known hypersensitivity to potassium chloride, severe renal failure, uncontrolled hyperkalemia, or in those taking multiple potassium‑increasing medications without appropriate monitoring. Contra‑indications must be confirmed by a qualified healthcare provider.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Potassium Chloride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT